Comments
Loading...

Ocugen Analyst Ratings

OCGNNASDAQ
Logo brought to you by Benzinga Data
$0.6946
At close: May 14, 7:47 PM EDT
$0.7000
0.005400.78%
After Hours: 7:47 PM EDT
Q1 2025 Earnings were released on Fri May 9th, before the market open
The most recent conference call was at 8:30 AM, 6 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$2.00
Consensus Price Target1
$5.17

Ocugen Analyst Ratings and Price Targets | NASDAQ:OCGN | Benzinga

Ocugen Inc has a consensus price target of $5.17 based on the ratings of 6 analysts. The high is $8 issued by Roth Capital on June 15, 2022. The low is $2 issued by Cantor Fitzgerald on August 31, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Chardan Capital on May 12, 2025, May 12, 2025, and March 6, 2025, respectively. With an average price target of $7 between HC Wainwright & Co., Chardan Capital, and Chardan Capital, there's an implied 900.00% upside for Ocugen Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov 24
2
Jan
2
Feb
2
Mar
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
Maxim Group
Cantor Fitzgerald
Mizuho

1calculated from analyst ratings

Analyst Ratings for Ocugen

Buy NowGet Alert
05/12/2025Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$8 → $7MaintainsBuyGet Alert
05/12/2025Buy Now900%Chardan Capital
Daniil Gataulin40%
$7 → $7MaintainsBuyGet Alert
03/06/2025Buy Now900%Chardan Capital
Daniil Gataulin40%
$6 → $7MaintainsBuyGet Alert
03/06/2025Buy Now1042.86%HC Wainwright & Co.
Swayampakula Ramakanth50%
$8 → $8ReiteratesBuy → BuyGet Alert
02/13/2025Buy Now757.14%Chardan Capital
Daniil Gataulin40%
$6 → $6MaintainsBuyGet Alert
02/13/2025Buy Now1042.86%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $8MaintainsBuyGet Alert
01/23/2025Buy Now757.14%Chardan Capital
Daniil Gataulin40%
$6 → $6MaintainsBuyGet Alert
01/13/2025Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
11/18/2024Buy Now757.14%Chardan Capital
Daniil Gataulin40%
$6 → $6MaintainsBuyGet Alert
11/14/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
11/11/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
11/08/2024Buy Now757.14%Chardan Capital
Daniil Gataulin40%
$6 → $6MaintainsBuyGet Alert
10/23/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
10/15/2024Buy Now471.43%Maxim Group
Michael Okunewitch27%
→ $4Initiates → BuyGet Alert
05/15/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
05/15/2024Buy Now614.29%Chardan Capital
Daniil Gataulin40%
$5 → $5MaintainsBuyGet Alert
04/22/2024Buy Now614.29%Chardan Capital
Daniil Gataulin40%
$4 → $5MaintainsBuyGet Alert
04/03/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $7ReiteratesBuy → BuyGet Alert
02/22/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $7ReiteratesBuy → BuyGet Alert
01/24/2024Buy Now900%HC Wainwright & Co.
Swayampakula Ramakanth50%
$5 → $7MaintainsBuyGet Alert
08/31/2023Buy Now185.71%Cantor Fitzgerald
Jennifer Kim43%
$2.5 → $2MaintainsOverweightGet Alert
08/23/2023Buy Now614.29%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $5ReiteratesBuy → BuyGet Alert
05/08/2023Buy Now471.43%Chardan Capital
Daniil Gataulin40%
$3.5 → $4MaintainsBuyGet Alert
04/17/2023Buy Now614.29%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $5Reiterates → BuyGet Alert
04/14/2023Buy Now400%Chardan Capital
Daniil Gataulin40%
→ $3.5MaintainsBuyGet Alert
03/01/2023Buy Now400%Chardan Capital
Daniil Gataulin40%
→ $3.5UpgradeNeutral → BuyGet Alert
03/01/2023Buy Now328.57%Mizuho
Uy Ear61%
$5 → $3MaintainsBuyGet Alert
03/01/2023Buy Now614.29%HC Wainwright & Co.
Swayampakula Ramakanth50%
$6 → $5Reiterates → BuyGet Alert
08/23/2022Buy Now614.29%Mizuho
Uy Ear61%
→ $5Initiates → BuyGet Alert
08/15/2022Buy Now757.14%HC Wainwright & Co.
Swayampakula Ramakanth50%
$7 → $6MaintainsBuyGet Alert
06/15/2022Buy Now1042.86%Roth Capital
Jonathan Aschoff34%
→ $8Reinstates → BuyGet Alert
06/02/2022Buy Now542.86%Cantor Fitzgerald
Jennifer Kim43%
→ $4.5Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Ocugen (OCGN) stock?

A

The latest price target for Ocugen (NASDAQ:OCGN) was reported by HC Wainwright & Co. on May 12, 2025. The analyst firm set a price target for $7.00 expecting OCGN to rise to within 12 months (a possible 900.00% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocugen (OCGN)?

A

The latest analyst rating for Ocugen (NASDAQ:OCGN) was provided by HC Wainwright & Co., and Ocugen maintained their buy rating.

Q

When was the last upgrade for Ocugen (OCGN)?

A

The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.

Q

When was the last downgrade for Ocugen (OCGN)?

A

There is no last downgrade for Ocugen.

Q

When is the next analyst rating going to be posted or updated for Ocugen (OCGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.

Q

Is the Analyst Rating Ocugen (OCGN) correct?

A

While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a maintained with a price target of $8.00 to $7.00. The current price Ocugen (OCGN) is trading at is $0.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch